Home About us Meet our experts Roelien Postema

Roelien Postema

Principal Market Access

Roelien advises clients on their access and evidence generation strategy from early assets through launch and beyond. She leads and contributes to a range of projects with a strategic angle in access, health economics and HTA policy.

Roelien brings over 14 years of experience in the field of health economics, market access, and real-world evidence. Through her roles at Lilly, BMS, and Galapagos, she has gained extensive experience in value and evidence generation strategy across a wide range of therapeutic areas, supporting countries in preparation of HTA dossiers, and development of evidence such as health economic models, indirect treatment comparisons, and real-world evidence studies. She also gained experience in providing health economics and market access insight into early drug development and for mergers and acquisitions.

Roelien has a PharmD from the University of Groningen and a Postgraduate Diploma in Epidemiology from the London School of Hygiene and Tropical Medicine.